Europe · Agences & temps réel · Reuters Europe Markets

South Africa's Aspen Pharmacare to sell women's health product in Europe to Ennogen

Publié par Reuters Europe Markets · Royaume-Uni il y a 18 h

South Africa's Aspen Pharmacare will sell the European commercialisation rights and related intellectual property for its women's health ‌product Ovestin to Ennogen Healthcare…

Lire l'article complet sur Reuters Europe Markets Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.reuters.com)

South Africa's Aspen Pharmacare to sell women's health product in Europe to Ennogen

À lire aussi

Teenager held in basement near Kiev beaten with shovel — publication

Brent crude falls nearly 8% below $105 as US-Iran diplomacy eases supply fears

Trading Day: Oil slump no cure for AI angst

Consumo de eletricidade sobe 3% até outubro e renováveis abastecem 62%

Fastmarkets clarifies China domestic steel scrap methodology guide

Binance hack plays up crypto’s trust issues

South Africa's Aspen Pharmacare to sell women's health product in Europe to Ennogen

Partager

À lire aussi

Teenager held in basement near Kiev beaten with shovel — publication

Brent crude falls nearly 8% below $105 as US-Iran diplomacy eases supply fears

Trading Day: Oil slump no cure for AI angst

Consumo de eletricidade sobe 3% até outubro e renováveis abastecem 62%

Fastmarkets clarifies China domestic steel scrap methodology guide

Binance hack plays up crypto’s trust issues